[go: up one dir, main page]

ECSP12011967A - Métodos y composiciones para el tratamiento rápido de otitis externa - Google Patents

Métodos y composiciones para el tratamiento rápido de otitis externa

Info

Publication number
ECSP12011967A
ECSP12011967A ECSP12011967A ECSP12011967A EC SP12011967 A ECSP12011967 A EC SP12011967A EC SP12011967 A ECSP12011967 A EC SP12011967A EC SP12011967 A ECSP12011967 A EC SP12011967A
Authority
EC
Ecuador
Prior art keywords
methods
compositions
treatment
quick treatment
external otitis
Prior art date
Application number
Other languages
English (en)
Inventor
Roland H Johnson
Douglas L Hepler
William R Campbell
Neil E Paulsen
Original Assignee
Bayer Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43992011&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP12011967(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Bv filed Critical Bayer Bv
Publication of ECSP12011967A publication Critical patent/ECSP12011967A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan métodos para el tratamiento y prevención de la otitis externa con un curso de tratamiento que consiste de tan poco como una sola dosis. Los métodos se practican mediante la administración tópica de las composiciones que tienen un portador de lípidos, tal como liposomas y lípidos no vesiculares, al canal auditivo externo. Estas composiciones carecen de celulosas o adhesivos que intensifican la viscosidad, y de preferencia no están en forma de gel. Los agentes activos útiles para el tratamiento de dolor, inflamación, infestación fungal o parasitaria y/o en el oído externo se co-administran en la composición o con la misma.
ECSP12011967 2009-11-11 2012-06-11 Métodos y composiciones para el tratamiento rápido de otitis externa ECSP12011967A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26030909P 2009-11-11 2009-11-11

Publications (1)

Publication Number Publication Date
ECSP12011967A true ECSP12011967A (es) 2012-08-31

Family

ID=43992011

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP12011967 ECSP12011967A (es) 2009-11-11 2012-06-11 Métodos y composiciones para el tratamiento rápido de otitis externa

Country Status (29)

Country Link
US (1) US8927006B2 (es)
EP (1) EP2498792B1 (es)
JP (2) JP2013510861A (es)
KR (2) KR101901083B1 (es)
CN (1) CN102612372B (es)
AU (1) AU2010319538B2 (es)
BR (1) BR112012011017A2 (es)
CA (1) CA2780160C (es)
CL (1) CL2012001227A1 (es)
CO (1) CO6540004A2 (es)
DK (1) DK2498792T3 (es)
EC (1) ECSP12011967A (es)
ES (1) ES2645200T3 (es)
HR (1) HRP20171520T1 (es)
HU (1) HUE034617T2 (es)
IL (1) IL219483A (es)
LT (1) LT2498792T (es)
MX (1) MX2012005521A (es)
MY (1) MY162687A (es)
NO (1) NO2498792T3 (es)
NZ (1) NZ599559A (es)
PH (1) PH12012500913A1 (es)
PL (1) PL2498792T3 (es)
PT (1) PT2498792T (es)
RU (1) RU2680137C2 (es)
SI (1) SI2498792T1 (es)
UA (1) UA111147C2 (es)
WO (1) WO2011060083A1 (es)
ZA (1) ZA201203239B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036165A1 (en) * 2012-08-29 2014-03-06 Bayer Healthcare, Llc Aqueous based compositions for treating otitis externa
CN104337952A (zh) * 2013-08-10 2015-02-11 李谊 一种中西医结合治疗爆震性耳聋的组合药物
CN104739768A (zh) * 2013-12-27 2015-07-01 河南惠通天下生物工程有限公司 一种甲砜霉素纳米脂质体及其制备方法
EP3482744A1 (de) * 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
AU2018367122A1 (en) * 2017-11-14 2020-06-04 Profem Gmbh Emulsions for the topical treatment of dermal infections and mucosal infections
CN115175667B (zh) * 2019-09-23 2024-06-04 迪迪艾斯研究公司 具有渗透促进剂的脂质囊泡组合物
AU2020361511B2 (en) * 2019-10-11 2025-12-18 Dechra Veterinary Products, Llc Otic formulations, methods and devices
EP4313100A4 (en) 2021-03-24 2025-10-15 Glo Pharma Inc PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION
CN113876658B (zh) * 2021-11-01 2023-10-20 仙乐健康科技股份有限公司 水包油型乳液组合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT744939E (pt) 1994-02-04 2003-02-28 Lipocore Holding Ab Preparacoes em bicamada preparadas a partir de digalactosildiacilglicerol contendo galactolipido
AU3609795A (en) * 1994-10-10 1996-05-02 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
WO1996039146A1 (en) * 1995-06-06 1996-12-12 Bayer Corporation Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
IT1295369B1 (it) 1997-10-21 1999-05-12 Fatro Spa Composizione a base di tiamfenicolo e diclofenac
US6433024B1 (en) * 2000-05-08 2002-08-13 Karl F. Popp Topical anti-acne composition
AUPR798901A0 (en) * 2001-09-28 2001-10-25 Medvet Science Pty. Ltd. Spheroidal hdl particles with a defined phospholipid composition
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
WO2004091578A2 (en) * 2003-04-09 2004-10-28 Biodelivery Sciences International, Inc. Novel encochleation methods, cochleates and methods of use
WO2005009436A1 (en) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Dispersible formulation of an anti-inflammatory agent
US20070054844A1 (en) 2003-08-20 2007-03-08 Fairfield Clinical Trials, Llc Method for treating otitis externa
US20050159369A1 (en) * 2003-08-20 2005-07-21 Qtm Llc Method of treatment of otitis externa
US20070078116A1 (en) * 2003-08-20 2007-04-05 Fairfield Clinical Trials, Llc Method of treatment of otitis externa
MX2007002462A (es) 2004-09-03 2007-10-10 Piedmont Pharmaceuticals Llc Metodo para el tratamiento de transmembrana y prevencion de la otitis media.
JP2008533048A (ja) * 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 耳の感染症の治療方法
US20090082337A1 (en) * 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections
US20090111780A1 (en) * 2007-10-31 2009-04-30 Everett Laboratories, Inc. Compositions and methods for treatment of ear canal infection and inflammation

Also Published As

Publication number Publication date
CL2012001227A1 (es) 2012-08-24
AU2010319538B2 (en) 2015-04-09
PH12012500913A1 (en) 2012-11-26
KR101901083B1 (ko) 2018-09-20
BR112012011017A2 (pt) 2015-09-15
KR20120116398A (ko) 2012-10-22
CA2780160C (en) 2018-03-06
EP2498792A4 (en) 2013-06-12
HUE034617T2 (en) 2018-02-28
CN102612372A (zh) 2012-07-25
EP2498792A1 (en) 2012-09-19
IL219483A0 (en) 2012-06-28
US8927006B2 (en) 2015-01-06
RU2680137C2 (ru) 2019-02-18
ZA201203239B (en) 2013-07-31
CO6540004A2 (es) 2012-10-16
RU2012124067A (ru) 2013-12-20
SI2498792T1 (sl) 2017-11-30
AU2010319538A1 (en) 2012-05-17
KR20170100680A (ko) 2017-09-04
DK2498792T3 (da) 2017-11-06
PL2498792T3 (pl) 2018-01-31
MX2012005521A (es) 2012-06-19
EP2498792B1 (en) 2017-08-02
US20110281809A1 (en) 2011-11-17
CN102612372B (zh) 2016-01-20
CA2780160A1 (en) 2011-05-19
NO2498792T3 (es) 2017-12-30
IL219483A (en) 2017-12-31
MY162687A (en) 2017-07-14
LT2498792T (lt) 2017-10-25
JP2013510861A (ja) 2013-03-28
JP2016102112A (ja) 2016-06-02
HRP20171520T1 (hr) 2017-11-17
NZ599559A (en) 2014-08-29
ES2645200T3 (es) 2017-12-04
PT2498792T (pt) 2017-10-18
WO2011060083A1 (en) 2011-05-19
JP6138891B2 (ja) 2017-05-31
UA111147C2 (uk) 2016-04-11

Similar Documents

Publication Publication Date Title
ECSP12011967A (es) Métodos y composiciones para el tratamiento rápido de otitis externa
DOP2012000225A (es) Compuestos de pirrolo-pirimidina como inhibidores de cdk4/6
CL2020000747A1 (es) Formulaciones de niraparib.
CU20150163A7 (es) DERIVADOS DE 5-HETEROARIL-4-FENIL-4,5-DIHIDROPIRROLO(3,4-c)PIRAZOL-6-ONA ACTIVOS COMO INHIBIDORES DE BET
CZ308507B6 (cs) Parazitické orální veterinární kompozice obsahující systémově působící aktivní činidla, způsoby a jejich použití
PH12016500024A1 (en) Bromodomain inhibitor
MX343215B (es) Composiciones farmacéuticas del compuesto espiro-oxindol para administración tópica y sus usos como agentes terapéuticos.
EA201591662A1 (ru) Липиды и липидные композиции для доставки активных агентов
NI201300041A (es) Antagonistas de mdm2 de espiro-oxindol
CR20110596A (es) Composiciones sublinguales de dexmedetomidina y métodos de uso de ellas
UY28862A1 (es) Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
DOP2011000382A (es) Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas
MX340985B (es) Compuestos de n-heteroarilo.
MX2012005013A (es) Pterostilbeno (peter) para su uso en la prevencion y/el tratamiento de enfermedades, daños o lesiones de la piel.
AR087790A1 (es) Uso de un inhibidor de aromatasa para el tratamiento de hipogonadismo y enfermedades relacionadas
CR11823A (es) Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenarativas e inflamatorias
MX2012013607A (es) Polisacarido de las semillas de tamarindo para usarse en el tatamiento de enfermedades inflamatorias.
AR083095A1 (es) Cocristal de aprepitant l-prolina y composicion farmaceutica
MX357704B (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
ECSP13012988A (es) Derivados de tienopirimidina (2,3-d) y su uso para tratar arritmia
BR112022004777A2 (pt) Composição de micela de estimulação imunológica
CR20160021A (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
NI201200196A (es) Agentes terapéuticos 976
UY33010A (es) Compuestos de pirazina fusionados como sus sales, útiles para el tratamiento de enfermedades degenerativas e inflamatorias
MX2019009909A (es) Composiciones farmaceuticas para terapia de combinacion.